Close

ESG Data

[Notes]
*The coverage of environmental accounting includes the Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.

*The coverage of social data is non-consolidated.

*The coverage of governance data is non-consolidated.

Environment

Category Coverage*1 FY2021 FY2022 FY2023
CO2emissions*2
Total(t-CO2 a,b,c,d 17,015
(16,887)
16,685 15,142
- Plants and research centers(t-CO2 14,277 14,153 12,868
- Office(t-CO2 694 591 460
- Commercial fleet(t-CO2 2,044 1,941 1,814
CO2 emissions by Scope*3
Scope 1(t-CO2 a,b,c,d 4,505 4,313 4,017
Scope 2(t-CO2 10,466 10,431 9,311
Scope 3
- Category 5:Waste generated in operations(t-CO2
- - 320 338
- Category 6:Business travel(t-CO2 - 1,236 2,077
- Category 7:Employee commuting(t-CO2 - 695 700
- Category 8:Upstream leased assets(t-CO2 - 1,941 1,814
- Category 12:End-of-life treatment of sold products(t-CO2 - 250 258
Energy
Total(GJ) a,b,c,d 359,304 353,482 347,617
- Electric power purchased(GJ) 238,006 236,980 235,290
- Heavy oil A(GJ) 0 0 0
- Gasoline(GJ) 30,483 28,926 27,029
- LNG(GJ) 66,871 65,242 63,692
- City gas(GJ) 23,933 22,324 21,579
- LPG(GJ) 11 10 27
- Steam(GJ) 0 0 0
Water resources*4
Water consumption(Thousand m3 a,b,c 354 348 306
- Groundwater(Thousand m3 352 344 301
- Public water(Thousand m3 2 4 5
Amount of wastewater(Thousand m3 323 310 306
- Sewerage(Thousand m3 9 13 15
- Other(Thousand m3 314 297 291
Water pollution*4
BOD(t) a,b,c 0.6 0.8 0.5
COD(t) 0.5 0.4 0.4
SS(t) 0.6 0.5 0.5
Waste*4
Waste generated(t) a,b,c 464 524 533
External recycled waste(t) 461 520 529
External recycled waste rate(%) 99.3 99.2 99.3
Final disposal(t) 3 4 4
Final disposal rate(%) 0.65 0.76 0.75
OA paper(Ten thousand sheets) 1,225 1,196 1,103
Air pollution
Particulate matter(t) a,b,c 0 0 0
SOx(t) 0 0 0
NOx(t) 0 0 0
PRTR discharge*5
Handled(t) a,b,c 1.2 1.5 0.2
Released into the atmosphere*6(t) 0 0 0
Released into water*6(t) 0 0 0
Transferred to sewerage*6(t) 0 0 0
Transferred to waste(t) 1.2 1.5 0.2
Containers and package
Container and package recycling(t) a,c 115 135 129
Environmental violations
Violation(Cases) a,b,c,d 0 0 0

*1
a.Mochida Pharmaceutical Co., Ltd.
b.Head Office Plant of Mochida Pharmaceutical Plant Co., Ltd.
c.Saitama Plant of Mochida Pharmaceutical Plant Co., Ltd.
d.Commercial fleet
*2 The CO2 emissions caused by electricity generation will be calculated using basic emission factor in FY2020 and FY2021, and adjusted emission factor in FY2022. The value in parentheses represents a reference value calculated using the adjusted emission factor.
*3 The CO2 emissions per scope by the GHG protocol
*4 Not includes branches and sales offices of Mochida Pharmaceutical Co.. Additionally, the data for FY2020 and FY2021 excludes data from Mochida Pharmaceutical Co., Ltd.'s headquarters, which was temporarily relocated. The data for FY2022 includes some data from Mochida Pharmaceutical Co., Ltd.'s headquarters (beginning operating out of the new office building from September 2022).
*5 Not includes branches and sales offices of Mochida Pharmaceutical Co., Ltd., because not applicable.
*6 <1t

Environmental accounting

Units:Thousand JPY

Category FY2023 Investments FY2023 Expenses
Environmental conservation costs*
Costs within our business areas 24,628 61,550
- Pollution prevention costs 0 45,972
- Global environmental conservation costs 24,628 1,207
- Resource recycling costs 0 14,371
Upstream & downstream costs 0 2,504
Environmental management costs 0 17,502
Environmental R&D costs 0 0
Social activity costs 5,374 577
Environmental remediation costs 0 0
Total 30,002 82,133
Category FY2022 FY2023 Y o Y
Environmental conservation benefits
CO2 emissions(t-CO2 10,228 8,879 ▲1,349
Electricity usage(Thousand kWh) 15,410 15,231 ▲179
Heavy oil usage(kL) 0 0 -
LNG usage(t) 1,195 1,167 ▲28
Water consumption(Thousand m3 240 198 ▲42
Water discharge for public waters(Thousand m3 231 232 1
Waste generated(t) 300 302 2

*Include the cost for enviromental conservation;
Partially include the cost for multiple parpose, in the propotion for enviroment-purpose;
Exclude the depreciation expense for fixed asset.

Social

Category FY2021 FY2022 FY2023
Employees information
Number of employees(Consolidated)(Persons) 1,544 1,529 1,522
Number of employees(Persons) 1,280 1,252 1,247
- Female(Persons) 369 378 385
Number of managers(Persons) 251 251 294
- Female(Persons) 27 30 34
Ratio of female managers(%) 10.8 12.0 11.6
- Target*(%) 12.0 12.0 12.0
Number of new recruits(Persons) 38 37 34
- Female(Persons) 24 23 18
Number of mid-career hires(Persons) 21 20 33
- Female(Persons) 6 3 9
Ratio of mid-career hires(%) 35.6 35.1 49.3
Ratio of disabled employees(%) 2.6 2.4 2.4
Average age(Years) 42.4 42.4 42.8
Average years of service(Years) 16.9 16.8 16.9
- Male(Years) 18.0 17.7 17.8
- Female Years) 14.4 14.7 15.0
Difference in average years of service between male and female(Years) 3.6 3.1 2.8
Average annual salary(JPY) 8,101,401 8,330,221 8,223,301
Gender pay gap*2 All workers(%) - 70.5 70.5
- Regular workers (%) - 72.3 72.0
- Part-time and fixed-term workers(%) - 53.9 54.6
Human resources development
Retention rate after 3 years(%) 90.5 95.2 86.8
Staff turnover rate*3(%) 2.8 3.4 3.2
Work-life balance
Number of employees who took holidays before and after childbirth leave(Persons) 19 16 19
Number of employees who took childcare leave(Persons) 68 40 48
- Female(Persons) 21 12 20
Ratio of male employees who took childcare leave(%) 90.3 75.6 76.9
Ratio of female employees who took childcare leave(%) 100 100 100
Number of employees using short-time work for childcare(Persons)) 35 37 36
Ratio of returning to work after childcare leave(%) 97.9 97.4 100
Occupational health and safety
Number of days of paid leave granted(Days) 19.2 19.2 19.2
Average usage of paid leave(Days) 11.3 12.0 12.8
Ratio of paid leave acquisition(%) 59.0 62.5 66.8
Average actual hours worked per year(Hours) 1,933 2,028 2,013
Average overtime hours per month(Hours) 5.0 6.4 5.9
Accident frequency rate*4 0 0 0.33
Employee stock ownership association
Number of members(Consolidated)(Persons) 582 591 583
Labor union
Number of members(Consolidated)(Persons) 1,006 996 986
Donations
Grant for study*5(Million JPY) 252 260 238

*1 The goal for FY2020 is until March 2021, while the goals for FY2021 and 2022 are until March 2026.
*2 Ratio of the average annual salary of female employees to the average annual salary of male employees
*3 Except for retired and a loan employee
*4 Number of deaths and injuries by Industrial accident/Total number of actual working hours×1,000,000
*5 Except for Conference co sponsorship fee

Governance

Category FY2021 FY2022 FY2023
Board of Directors
Number of the Board(Persons) 10 10 11
- Outside members(Persons) 3 3 4
- Female members(Persons) 1 1 1
Audit & Supervisory Board
Number of Audit & Supervisory Board members (Persons) 5 5 5
- Outside members(Persons) 3 3 3
- Female members(Persons) 1 1 1
Officers' compensation of directors
Total(Million JPY) 309 347 272
Officers' compensation of Audit & Supervisory Board member
Total(Million JPY) 65 65 65
Nomination and Compensation Advisory Committee
Ratio of Independent board member(%) 66.6 66.6 66.6
Meeting frequency
Board of Directors(Times) 13 13 14
Audit & Supervisory Board(Times) 16 16 16
Page top